---
title: "NeuroOne reports successful large-animal procedures using next-generation StereoCED platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297191400.md"
description: "NeuroOne completed three large-animal procedures using its next-generation StereoCED platform for robotic-assisted intracerebral drug delivery, achieving targeted delivery with simultaneous electrophysiological recording. This work supports a planned launch for human investigational clinical studies later this quarter. Animal-use devices finished early, with revenue expected in fiscal Q4 2026, while human-use devices remain on track for release by the end of fiscal Q4 2026."
datetime: "2026-08-27T13:06:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297191400.md)
  - [en](https://longbridge.com/en/news/297191400.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297191400.md)
generator: "portal-rs"
---

# NeuroOne reports successful large-animal procedures using next-generation StereoCED platform

-   NeuroOne completed three large-animal procedures using its next-generation StereoCED platform for robotic-assisted intracerebral drug delivery. \* Two procedures achieved targeted drug delivery with simultaneous intracranial electrophysiological recording from the same brain regions. \* Work supports a planned launch for human investigational clinical studies later this quarter. \* StereoCED devices for animal use finished early, enabling earlier sales; related revenue is expected to be recognized in fiscal Q4 2026. \* Devices for human investigational use remain on track for release by the end of fiscal Q4 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-094174), on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md)

## Related News & Research

- [NeuroOne Advances StereoCED Toward Human Clinical Studies](https://longbridge.com/en/news/297210429.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)
- [06:56 ETHow travelers can support wild animals rather than exploit them](https://longbridge.com/en/news/297901620.md)
- [Stronger Q2 Results And Raised 2026 Outlook Could Be A Game Changer For IDEXX Laboratories (IDXX)](https://longbridge.com/en/news/298111178.md)
- [Deconstructing the DePIN Robotics Track: A Realistic Picture of Cryptographic Construction](https://longbridge.com/en/news/297994308.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**